Potent and selective β2-adrenoceptor agonist (EC50 = 5.3 nM); bronchodilator. Unlike other β2 agonists, binds to exo-site domain of β2 receptors, producing a slow onset of action and prolonged activation. Also available as part of the β-Adrenoceptor Agonist Tocriset™.
Sold for research purposes under agreement from GlaxoSmithKline
|Storage||Store at +4°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
References are publications that support the biological activity of the product.
Clark et al (1996) Stable activation and desensitization of β2-adrenergic receptor stimulation of adenylyl cyclase by salmeterol: evidence for quasi-irreversible binding to an exosite. Mol.Pharmacol. 49 182 PMID: 8569705
Ellis et al (1995) Correlation of cyclic AMP accumulation and relaxant actions of salmeterol and salbutamol in bovine tracheal smooth muscle. Br.J.Pharmacol. 116 2510 PMID: 8581292
Johnson et al (1993) The pharmacology of salmeterol. Life Sci. 52 2131 PMID: 8099695
View Related Products by Product Action
Keywords: Salmeterol, Salmeterol supplier, Potent, α2-adrenoceptor, beta2-adrenoceptor, b2-adrenoceptor, agonists, long, acting, β2-adrenergic, α2-adrenergic, beta2-adrenergic, b2-adrenergic, Receptors, GR33343, GlaxoSmithKline, GSK, GR, 33343, Adrenergic, Beta-2, 1660, Tocris Bioscience
Citations for Salmeterol
Citations are publications that use Tocris products.
Currently there are no citations for Salmeterol.
Reviews for Salmeterol
There are currently no reviews for this product. Be the first to review Salmeterol and earn rewards!
Have you used Salmeterol?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.